Douglas to speak on bioinnovations at next OVA meeting
The Ohio Venture Association will focus on the world of biomedical technology when Frank Douglas, President and CEO of the Akron BioInnovation Institute, speaks at its upcoming lunch meeting.
CEO of Austen BioInnovation Institute in Akron makes cover of… GQ?
A nationally-renowned medical researcher will be featured in next month’s issue of GQ Magazine as a Rock Star of Science. Dr. Frank L. Douglas says the honor was unexpected, but “a thrill.” Douglas, 67, is founder and CEO of the Austen BioInnovation Institute of Akron. Since joining ABIA in September 2009, Douglas has led an […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
New leader of BioInnovation Institute in Akron: Climbing ‘Mount Everest of social and medical transformation’
Frank L. Douglas was living a comfortable life as a senior fellow at the Ewing M. Kauffman Foundation; senior partner of Puretech Ventures and chief scientific adviser of Bayer Healthcare. On Sept. 1, the British Guyana native who has an undergraduate degree from Lehigh University, and Ph.D. and M.D. degrees from Cornell University will become the first president and chief executive of the BioInnovation Institute in Akron.